-DOCSTART- -X- O
The -X- _ O
humoral -X- _ O
arm -X- _ O
of -X- _ O
innate -X- _ O
immunity -X- _ O
is -X- _ O
complex -X- _ O
and -X- _ O
includes -X- _ O
various -X- _ O
molecules -X- _ O
that -X- _ O
serve -X- _ O
as -X- _ O
markers -X- _ O
of -X- _ O
inflammation -X- _ O
with -X- _ O
complementary -X- _ O
characteristics -X- _ O
, -X- _ O
such -X- _ O
as -X- _ O
the -X- _ O
short -X- _ B-Intervention
pentraxins -X- _ I-Intervention
C- -X- _ I-Intervention
reactive -X- _ I-Intervention
protein -X- _ I-Intervention
( -X- _ I-Intervention
CRP -X- _ I-Intervention
) -X- _ I-Intervention
and -X- _ I-Intervention
serum -X- _ I-Intervention
amyloid -X- _ I-Intervention
P -X- _ I-Intervention
( -X- _ I-Intervention
SAP -X- _ I-Intervention
) -X- _ I-Intervention
and -X- _ I-Intervention
the -X- _ I-Intervention
long -X- _ I-Intervention
pentraxin -X- _ I-Intervention
PTX3. -X- _ I-Intervention
There -X- _ O
is -X- _ O
a -X- _ O
growing -X- _ O
amount -X- _ O
of -X- _ O
evidence -X- _ O
– -X- _ O
including -X- _ O
mouse -X- _ O
and -X- _ O
human -X- _ O
genetics -X- _ O
– -X- _ O
that -X- _ O
suggests -X- _ O
that -X- _ O
PTX3 -X- _ B-Outcome
is -X- _ I-Outcome
essential -X- _ I-Outcome
in -X- _ I-Outcome
conferring -X- _ I-Outcome
host -X- _ I-Outcome
resistance -X- _ I-Outcome
against -X- _ I-Outcome
selected -X- _ I-Outcome
pathogens -X- _ I-Outcome
and -X- _ I-Outcome
, -X- _ I-Outcome
moreover -X- _ I-Outcome
, -X- _ I-Outcome
that -X- _ I-Outcome
it -X- _ I-Outcome
plays -X- _ I-Outcome
a -X- _ I-Outcome
dual -X- _ I-Outcome
antagonistic -X- _ I-Outcome
role -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
regulation -X- _ I-Outcome
of -X- _ I-Outcome
inflammation. -X- _ I-Outcome
Dissection -X- _ O
of -X- _ O
such -X- _ O
a -X- _ O
yin-and-yang -X- _ O
role -X- _ O
of -X- _ O
pentraxins -X- _ B-Intervention
in -X- _ O
immunity -X- _ O
and -X- _ O
inflammation -X- _ O
is -X- _ O
timely -X- _ O
and -X- _ O
significant -X- _ O
as -X- _ O
it -X- _ O
may -X- _ O
pave -X- _ O
the -X- _ O
way -X- _ O
for -X- _ O
better -X- _ O
clinical -X- _ O
exploitation -X- _ O
against -X- _ O
various -X- _ O
diseases -X- _ O
. -X- _ O

